Search

Learn about a noninvasive lung cancer test called "E-nose" that is being investigated at Memorial Sloan Kettering.

… Monday, July 8, 2024 Detecting  lung cancer as early as possible has long been a goal of the specialists at MSK, because it gives doctors the most treatment options, which can improve outcomes for patients.    A team led by MSK  thoracic surgeon Gaetano Rocco, MD , reported results in a clinical trial

Conozca una prueba no invasiva para el cáncer pulmonar llamada “nariz electrónica” que está siendo investigada en Memorial Sloan Kettering.

… Monday, July 8, 2024 Detectar el  cáncer pulmonar lo antes posible ha sido durante mucho tiempo un objetivo de los especialistas de MSK, ya que les brinda a los médicos más opciones de tratamiento, lo que puede mejorar los resultados para los pacientes.    Un equipo dirigido por el cirujano torácico

How scientists are working to develop nonmammalian alternatives that could reduce the number of rodents used in biomedical research.

… Thursday, January 12, 2023 Rats and mice have been the backbone of biomedical research for decades — including research to understand cancer and pioneer new treatments. New drug compounds are tested for safety and effectiveness in animal models before being approved for clinical trials in humans. Jan

Dr. Tagore is a postdoctoral fellow in the Cancer Biology and Genetics Program at the Sloan Kettering Institute studying cell communication in cancer.

… Monday, June 8, 2020 Summary Mohita Tagore is a postdoctoral fellow in the Cancer Biology and Genetics Program at the Sloan Kettering Institute. She is a 2020 winner of a Kravis WISE postdoctoral fellowship and will be presenting her research at the inaugural Kravis WiSE Symposium on July 8, 2020. In

After immunotherapy and targeted therapy failed to bring a patient's melanoma under control, MSK doctors offered her a new treatment called tumor-infiltrating lymphocyte, or TIL, therapy.

… Tuesday, October 28, 2025 It was not the news that Pattie Fuller wanted to hear.  Doctors at a local hospital in upstate New York told her that despite surgery and several rounds of  immunotherapy , her  melanoma was growing. The melanoma ultimately grew to be stage 4. It spread from her scalp to the

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

… Wednesday, September 15, 2021 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: MSK Receives National Cancer Institute (NCI) Specialized Programs of Research Excellence (SPORE) Grant Omar Abdel-Wahab and Martin Tallman The National Cancer Institute (NCI) awarded

Despite significant advances in supportive care and improvements in allogeneic hematopoietic stem cell transplantationoutcomes, about one in every three patients succumbs to post-transplant toxicities, half of which are not related to graft-versus-host disease.

… Thursday, March 15, 2018 Despite significant advances in supportive care and improvements in allogeneic hematopoietic stem cell transplantation outcomes, about one in every three patients succumbs to post-transplant toxicities, half of which are not related to graft-versus-host disease (GVHD). While

The third annual research symposium introduces high school students and teachers to several topics in cancer research.

… Sunday, March 1, 2009 Summary The third annual research symposium introduces high school students and teachers to several topics in cancer research. An important part of Memorial Sloan Kettering’s mission has always been education. As part of that goal, an annual symposium called Major Trends in Modern

Learn about the work of Mehmet Erman Karasu, a recent graduate of the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK), has been awarded the 2019 Chairman’s Prize.

… Monday, August 19, 2019 Mehmet Erman Karasu, a recent graduate of the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) , has been awarded the 2019 Chairman’s Prize. The competitive award is presented annually and was established by GSK’s Board of Trustees Chair Louis V. Gerstner,

“Plum” from the Caring Canines program will compete June 11-13.

… Wednesday, June 9, 2021 “Plum,” a therapy dog in the MSK Caring Canines program, is competing in the 2021 Westminster Kennel Club Dog Show on June 11-13. Plum, who is a black Flat-Coated Retriever, is owned by MaryJane Koren, a retired geriatric doctor who has been a volunteer in the Caring Canines program